Literature DB >> 29658327

Adherence to Oral Anticoagulants in Atrial Fibrillation: An Australian Survey.

Kehinde O Obamiro1, Leanne Chalmers1, Kenneth Lee1, Bonnie J Bereznicki1, Luke R Bereznicki1.   

Abstract

BACKGROUND: The aim of this study was to investigate the proportion of patients who have suboptimal adherence to oral anticoagulant (OAC), identify the predictors of adherence, and determine whether patient-related factors vary across adherence levels in Australia.
METHODS: Respondents were recruited for an online survey using Facebook. Survey instruments included the Morisky Medication Adherence Scale, the Anticoagulation Knowledge Tool, the Perception of Anticoagulant Treatment Questionnaires, and a modified Cancer Information Overload scale. Predictors of medication adherence were identified using ordinal regression analysis.
RESULTS: Of the 386 responses eligible for analysis, only 54.9% reported a high level of adherence. Participants aged 65 years or younger were less likely to have high adherence compared to older participants (odds ratio [OR], 0.54; 95% confidence interval [CI], 0.33-0.88; P = .013), while females were more likely to be highly adherent compared to males (OR, 1.69; 95% CI, 1.08-2.64; P = .023). The analyses showed that age, gender, treatment satisfaction, information overload, concerns about making mistake when taking OACs, and cost of medication were significant predictors of adherence.
CONCLUSION: Self-reported suboptimal adherence to OAC is common among patients with atrial fibrillation. A focus on supporting people who are at higher risk of suboptimal adherence is needed to maximize the benefit of OAC therapy in this population.

Entities:  

Keywords:  adherence; atrial fibrillation; heart disease; oral anticoagulant

Mesh:

Substances:

Year:  2018        PMID: 29658327     DOI: 10.1177/1074248418770201

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol Ther        ISSN: 1074-2484            Impact factor:   2.457


  4 in total

1.  A systematic review of patient-reported outcomes associated with the use of direct-acting oral anticoagulants.

Authors:  Saima Kishvar Afzal; Syed Shahzad Hasan; Zaheer Ud-Din Babar
Journal:  Br J Clin Pharmacol       Date:  2019-06-26       Impact factor: 4.335

Review 2.  Shared decision-making in atrial fibrillation: navigating complex issues in partnership with the patient.

Authors:  Peter A Noseworthy; Juan P Brito; Marleen Kunneman; Ian G Hargraves; Claudia Zeballos-Palacios; Victor M Montori; Henry H Ting
Journal:  J Interv Card Electrophysiol       Date:  2018-10-17       Impact factor: 1.900

3.  Cognitive Impairment Is Independently Associated with Non-Adherence to Antithrombotic Therapy in Older Patients with Atrial Fibrillation.

Authors:  Hyun-Joo Seong; Kyounghoon Lee; Bo-Hwan Kim; Youn-Jung Son
Journal:  Int J Environ Res Public Health       Date:  2019-07-29       Impact factor: 3.390

4.  Impact of Medication Adherence on the Association Between Oral Anticoagulant Use and Risk of Dementia: A Retrospective Cohort Study using the Japanese Claims Database.

Authors:  Yuika Komatsu; Satoshi Yokoyama; Kouichi Hosomi; Mitsutaka Takada
Journal:  Drugs Real World Outcomes       Date:  2022-06-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.